AzTrials
AzTrials

Hypotension During SurgeryPhase 4NCT07052864

IV Dexamethasone in Preventing Post Spinal Hypotension

A Phase 4 study testing Dexamethasone in people with Hypotension During Surgery, run by Pakistan Institute of Medical Sciences at 1 site in Pakistan.

Active, not recruiting

Under way, not looking for participants. Everyone needed has enrolled. The study is still running.

Official record
Search all trials

Trial summary

Orthopedic lower limb procedures are carried out under spinal anesthesia which involves administration of drugs in the space surrounding the spinal cord. From there the drug acts on the spinal cord blocking electrical signals moving across nerve fibers thereby providing sufficient pain relief and surgical conditions. Read more about this study

Who is it for?
Ages 50 to 100 yearsHealthy volunteers can take part
Conditions the study is for
Hypotension During Surgery
What is being tested?
Dexamethasone
Type of treatment
Injection or infusion
Could I receive a placebo?
Yes, some participants may receive a placebo
How many people
134 participants
Where
1 sitePakistan
Study dates
30 Jun 2025to 5 Aug 2025
Phase
Phase 4
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 50 to 100 years
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • Patients undergoing orthopedic surgery under spinal anaesthesia.
  • ASA I \& II.

Who cannot join

  • Known case of ischemic heart disease.
  • Patients having contraindication to spinal anesthesia (e.g.- coagulopathy, thrombocytopenia, allergy to local anesthetic agent).
  • Patients using corticosteroids or drugs that affect serotonin (e.g., selective serotonin reuptake inhibitor).
  • Patients with uncorrected hypovolemia.

Trial locations and contacts

1 site in 1 country.

Pakistan1 site
  • Deparment of Anesthesia and Critical Care Medicine, Pakistan Institute of Medical Sciences

    Islamabad, Federal, 44000

Other trials in Pakistan

About this study

Official title: Efficacy of Dexamethasone in Preventing Postspinal Hypotension in Elderly Patients Undergoing Orthopedic Surgery: a Randomized Controlled Study

Orthopedic lower limb procedures are carried out under spinal anesthesia which involves administration of drugs in the space surrounding the spinal cord. From there the drug acts on the spinal cord blocking electrical signals moving across nerve fibers thereby providing sufficient pain relief and surgical conditions. However blocking of these fibers result in reduce signal transmission to blood vessels and heart resulting in fall in blood pressure. Various drugs can be used to treat or prevent this hypotension. One such drug is Dexamethasone which is a steroid. This drug can be administered before spinal anesthesia through Intravenous route to prevent fall in blood pressure.

Read the detailed description

Lower limb orthopedic surgeries are carried out under Sub Arachnoid block which is associated with sympathectomy resulting in vasodilation and hypotension. The hypotension can compromise end organ perfusion and pre-disposes the person to end organ damage such as Myocardial infarction, stroke and renal injury. Therefore treatment and prevention of post spinal hypotension is one of the major goals to improve peri-operative outcomes. One such drug which can be used to prevent post spinal hypotension is Dexamethasone which can be given prophylactically to prevent post spinal hypotension as the drug causes increase in systemic vascular resistance thereby counteracting post spinal vasodilation and hypotension.

Being tested
Dexamethasone, Placebo

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • DexamethasoneDrug

    8 mg of Intravenous Dexamethasone in 100 ml Normal saline given 1 hour before anesthesia induction

  • PlaceboDrug

    Also called Normal Saline

    100ml of Normal saline administration 1 hour before anesthesia induction

Study groups in NCT07052864
Study groupRoleWhat they receive
Group DexamethasoneExperimentalParticipants entering this arm of Parallel randomized control trial will receive 8mg of IV Dexamethasone in 100ml Normal saline 1 hour before induction of spinal anesthesia.
Receives: Drug: Dexamethasone
Group PlaceboPlacebo comparatorParticipants entering this arm of Parallel randomized control trial will receive 100ml Normal saline 1 hour before induction of spinal anesthesia.
Receives: Drug: Placebo

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Systolic Blood Pressure

    This is the highest blood pressure during cardiac cycle occurring at the peak of systole measured by Non invasive automated blood pressure cuff

    Measured: baseline, 5 mins, 10 mins, 15 mins, 20 mins, 25 mins,30 mins

  2. Diastolic Blood Pressure

    This is the lowest blood pressure during cardiac cycle measured by Non invasive automated blood pressure cuff

    Measured: baseline, 5 mins, 10 mins, 15 mins, 20 mins, 25 mins,30 mins

  3. Mean Blood Pressure

    This is the average blood pressure during cardiac cycle measured by Non invasive automated blood pressure cuff

    Measured: baseline, 5 mins, 10 mins, 15 mins, 20 mins, 25 mins,30 mins

Secondary outcomes (3)
  1. Number of Hypotensive episodes

    This will be the number of times in the intraoperative period the patient experience fall in either systolic, diastolic or mean blood pressure by more than 20% from baseline

    Measured: Intraoperative period

  2. Rescue Phenylephrine

    This will be the total amount of phenylephrine administered in intraoperative period to the patient in case of fall in either systolic, diastolic or mean blood pressure by more than 20% from baseline

    Measured: Intraoperative period

  3. Rescue intravenous fluid

    This will be the total amount of IV crystalloid fluid administered in intraoperative period to the patient in case of fall in either systolic, diastolic or mean blood pressure by more than 20% from baseline

    Measured: Intraoperative period

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted7 Jul 2025
  2. Study start30 Jun 2025
  3. Primary completion5 Aug 2025 (estimated)
  4. Study completion5 Aug 2025 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase 4
Primary purpose
Prevention
Allocation
Randomised
Intervention model
Parallel groups
Model description
After taking informed consent participants will be divided into two equal groups using computer generated random numbers. The participants in group D will receive 8 mg of IV Dexamethasone in 100ml Normal saline 1 hour before induction of spinal anesthesia while participants in group C will receive 100ml of Normal saline 1 hour before induction of spinal anesthesia. 1 hour after administration of IV Dexamethasone or placebo patient will be brought into OR, ASA monitoring will be attached, Sub Arachnoid block will be induced with 15mg of hyperbaric bupivacaine, patient will be made to lie down, level of block will be assessed and surgery will be started. Intraoperatively hemodynamics will be recorded at 5 minutes interval for first 30 minutes. Any fall in blood pressure by more than 20% from baseline will be noted and treated with Phenylephrine IV bolus.
Masking
Double blind
Who is masked
Participant, Outcomes assessor
Enrolment
134 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07052864
Sponsor's protocol ID
F.5-2/2024(ERRC)/PIMS
Status last verified
Jun 2025
First submitted
29 Jun 2025
Last updated
31 Jul 2025
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
Yes
FDA-regulated device
No
Individual data sharing
No

Publications

  • Ashoor TM, Hussien NS, Anis SG, Esmat IM. Dexamethasone blunts postspinal hypotension in geriatric patients undergoing orthopedic surgery: a double blind, placebo-controlled study. BMC Anesthesiol. 2021 Jan 11;21(1):11. doi: 10.1186/s12871-021-01232-w.

    PubMed 33430772

Questions about this trial

What is this clinical trial studying?

A Phase 4 study testing Dexamethasone in people with Hypotension During Surgery, run by Pakistan Institute of Medical Sciences at 1 site in Pakistan.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: under way, not looking for participants, as of the sponsor's last update on 31 Jul 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Pakistan. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

What does this phase mean?

Phase 4 studies take place after a treatment is approved, to learn more about its long-term benefits and risks in everyday use.

Not every study follows the same path, and some studies (observational studies, device studies) have no phase.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Systolic Blood Pressure (time frame: baseline, 5 mins, 10 mins, 15 mins, 20 mins, 25 mins,30 mins). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT07052864, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 31 Jul 2025.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in